bioRxiv Science⌕ Search

Biology subjects

Dougnon, V.

Publications and source records attributed to Dougnon, V..

2 recordsLinked to original sources

Serotypes of Dengue Virus and Kdr Mutations F1534C, S989P, V410L, V1016I, and V1016G in Aedes aegypti and Aedes albopictus Mosquitoes from the commune of AbomeyCalavi, Southern Benin

Dengue is a viral infection transmitted by mosquitoes of the Aedes genus, responsible for millions of cases each year. In Benin, several outbreaks have been reported, particularly in Abomey-Calavi, where the first dengue-related death was recorded in 2019. In the absence of a specific treatment, vector control remains the primary preventive measure. However, the emergence of insecticide resistance, notably through kdr mutations, could compromise its effectiveness. This study aims to identify the dengue virus serotypes circulating in the commune of Abomey-Calavi and to assess the frequency of kdr mutations V410L, V1016G, V1016I, F1534C, and S989P in Aedes aegypti and Aedes albopictus mosquitoes. Mosquitoes were collected in August 2024 from four arrondissement Togba, Calavi, Akassato, and Godomey through morning and afternoon spraying. After morphological identification, molecular analyses were conducted to detect the viral serotypes and kdr mutations. A total of 218 Aedes mosquitoes were collected, with a predominance of Aedes aegypti (68.8%) compared to Aedes albopictus (31.2%). The overall dengue positivity rate was 23.39% (95% CI: 17.9 - 29.6). The most frequent serotype was DENV-3 (12.4%), followed by DENV-2 (6.9%), DENV-1 (5%), and DENV-4 (0.09%). Six mosquitoes were co-infected with two serotypes, including three with DENV-1 and DENV-4. kdr mutations were detected in both species, with frequencies of 45% for V1016G, 44% for S989P, 40% for F1534C, 22% for V410L, and 19% for V1016I. Four mosquitoes carried three simultaneous mutations, while twenty-two carried two. Two mosquitoes co-infected with two serotypes also carried two different mutations. These results highlight the active circulation of the dengue virus and the presence of kdr mutations in Aedes mosquitoes in Abomey-Calavi. However, no significant association was observed between dengue infection and kdr mutations, and their distribution was independent of the viral serotype. These findings emphasize the need for regular monitoring of kdr mutations to adapt vector control strategies and limit the spread of dengue.

biochemistry↗

Unlocking the potential of Uvaria chamae: A cream formulation for combatting Staphylococcus aureus skin infections

Staphylococcus aureus (S. aureus) skin infections remain a prevalent public health concern worldwide, posing ongoing challenges in treatment. Uvaria chamae roots has demonstrated significant effectiveness against S. aureus. This study aimed to propose a dermal formulation based on Uvaria chamae for treating bacterial skin infections. The antibacterial activity was first confirmed. Tests including the time-kill test, the erythromycin outer membrane permeability test, and the ATPase/H+ proton pump inhibition test were conducted to explore the antibacterial mode of action. A cream was prepared using the phase inversion technique and subjected to quality control and senso-rheological testing. The cream was tested for antibacterial activity and skin toxicity (OECD guideline 404). The in vivo antibacterial effect and wound-healing potential of the Uvaria chamae cream were then assessed on Wistar rat. The ethanolic extract of Uvaria chamae root exhibited bactericidal effects on the tested S. aureus strains. In combination with erythromycin, the extract enhanced the permeability of S. aureuss outer membrane while inhibiting ATPase/H+ proton pumps. The pharmaceutical quality of the produced cream revealed acceptable macroscopic conditions and satisfactory homogeneity. Antibacterial activity evaluation showed significant activity at low concentrations. The creams healing properties indicated a significant decrease in wound diameter (p<0.05) over time, culminating in complete healing on day 13 for the treated group, with a retraction percentage of 99.99%. These findings support the safe use of Uvaria chamae extracts in managing S. aureus skin infections and pave the way for pre-clinical testing and potential market introduction of this cream.

microbiology↗